Abstract
Discovering safe, novel immunomodulators that are effective in RA is currently a major therapeutic objective. Long-term immune system deviation is most striking in the host-parasite relationship, in which microbes may coexist with a human host. ES-62 exhibited powerful immunomodulation of CIA, preventing initiation of inflammatory arthritis. Crucially, ES-62 suppressed even established disease. These effects were due to inhibition of cytokine release, specifically TNF-α, and reversal of collagen specific Th1 responses associated with reduced expression of IFN-γ. The physiologic relevance of these observations was confirmed, as ES-62 down-regulated the release of proinflammatory cytokines (TNF-α and IL-6) from patient-derived samples.
| Original language | English |
|---|---|
| Pages (from-to) | 52-52 |
| Number of pages | 1 |
| Journal | Arthritis Research and Therapy |
| Volume | 5 |
| Issue number | Suppl 1 |
| DOIs | |
| Publication status | Published - 24 Feb 2003 |
| Event | 23rd European Workshop for Rheumatology Research - Marseille, France Duration: 27 Mar 2003 → … |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- cytokine modulation
- physiology
- immunology
- articular inflammation
Fingerprint
Dive into the research topics of 'A novel therapeutic approach to cytokine modulation in articular inflammation using filarial nematode derived ES-62'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver